Gigot J F, Deprez P, Sempoux C, Descamps C, Metairie S, Glineur D, Gianello P
Department of Digestive Surgery, St-Luc University Hospital, Université Catholique de Louvain, Brussels, Belgium.
Arch Surg. 2001 Nov;136(11):1256-62. doi: 10.1001/archsurg.136.11.1256.
Resection of intraductal papillary mucinous tumors of the pancreas (IPMTP) should be tailored to longitudinal spreading into the pancreatic ductal system and the presence of malignant transformation.
To review a single institutional experience with IPMTP, focusing on the operative strategy of tailoring resection to the extent of disease.
Retrospective study.
Academic tertiary referral center.
Thirteen patients with IPMTP were referred for resection during the past 10 years. Malignant growth was present in 7 patients (54%). According to the determination of tumor extent, distal pancreatic resection was performed in 3 patients, pancreatoduodenectomy was done in 9 patients, and total pancreatectomy was performed in 1 patient. The median follow-up time in this series was 46 months (range, 3-104 months).
Preoperative and perioperative diagnosis, final pathologic results, and long-term outcome.
A correct preoperative or perioperative diagnosis of IPMTP was achieved in 9 patients (69%). Routine frozen section of the surgical margin was used in all patients, changing the operative strategy in 3 (23%) of 13 patients by extending resection or leading to total pancreatectomy in 2 patients and 1 patient, respectively. A perioperative endoscopic examination of the Wirsung duct was performed in 3 patients with a correct preoperative or perioperative diagnosis of IPMTP and a dilated pancreatic duct. This allowed the examination of the entire pancreatic ductal system and staged intraductal biopsies, changing the operative strategy in 1 of these patients. Finally, after pancreatoduodenectomy, pancreaticogastric anastomosis was constructed in 5 patients, allowing endoscopic assessment of the pancreatic stump during long-term follow-up. The 5-year actuarial survival rate was 56.8% in the whole series. All patients with benign or microinvasive malignant disease remained disease-free, whereas all patients with invasive malignant disease died of tumor recurrence.
Accurate determination of the extent of ductal disease and residual malignant growth, when present, is critical during surgical exploration to achieve radical resection and cure. Operative strategy should be based on routine frozen section of the surgical margin and perioperative endoscopic examination of the Wirsung duct with staged intraductal biopsies when technically feasible. The routine use of pancreaticogastric anastomosis after pancreatoduodenectomy allows easy, safe, and efficient long-term endoscopic assessment of the pancreatic stump.
胰腺导管内乳头状黏液性肿瘤(IPMTP)的切除术应根据其在胰管系统中的纵向扩散情况以及是否存在恶性转化来进行调整。
回顾单一机构对IPMTP的治疗经验,重点关注根据疾病范围调整切除术的手术策略。
回顾性研究。
学术性三级转诊中心。
在过去10年中,13例IPMTP患者被转诊接受切除术。7例患者(54%)存在恶性生长。根据肿瘤范围的判定,3例行胰体尾切除术,9例行胰十二指肠切除术,1例行全胰切除术。本系列患者的中位随访时间为46个月(范围3 - 104个月)。
术前和围手术期诊断、最终病理结果及长期预后。
9例患者(69%)术前或围手术期对IPMTP做出了正确诊断。所有患者均常规进行手术切缘的冰冻切片检查,13例患者中有3例(23%)据此改变了手术策略,其中2例和1例分别通过扩大切除范围或改行全胰切除术。3例术前或围手术期诊断为IPMTP且胰管扩张的患者接受了围手术期对主胰管的内镜检查。这使得能够检查整个胰管系统并进行分期的胰管内活检,其中1例患者据此改变了手术策略。最后,在胰十二指肠切除术后,5例患者采用了胰胃吻合术,以便在长期随访期间对胰残端进行内镜评估。整个系列的5年总生存率为56.8%。所有良性或微浸润性恶性疾病患者均无疾病复发,而所有浸润性恶性疾病患者均死于肿瘤复发。
在手术探查期间,准确判定导管病变范围和残留恶性生长情况(若存在)对于实现根治性切除和治愈至关重要。手术策略应基于手术切缘的常规冰冻切片检查以及在技术可行时对主胰管进行围手术期内镜检查并进行分期的胰管内活检。胰十二指肠切除术后常规采用胰胃吻合术可便于、安全且有效地对胰残端进行长期内镜评估。